Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Shares of ResMed Inc. RMD rose 2.02% to $224.16 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 and the ...

Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to connectivity, ...

Resmed (RMD) announced a comprehensive brand evolution designed to unify its brand portfolio to serve more people and healthcare providers ...

Resmed, a leader in health technology focused on sleep and respiratory care, has announced a significant brand evolution aimed at unifying its portfolio and enhancing direct consumer engagement.

Citi has upgraded its rating on ResMed shares to a buy, joining a long list of fellow brokers in doing so. Let's dive in and ...

Shares of ResMed Inc. RMD shed 4.58% to $225.79 Tuesday, on what proved to be an all-around rough trading session for the ...

Highlights,Hedge funds and financial firms have adjusted their positions in ResMed, reflecting institutional activity.,The ...

Highlights,Institutional adjustments reflect growing interest in ResMed Inc., with several firms increasing their ...